Northern Light Venture Capital

Northern Light Venture Capital (NLVC) is a globally minded, tech-centric venture firm investing at the intersection of enterprise, healthcare, and consumer opportunities. Since 2005, NLVC has grown as an extensive platform focused on long-term enterprise, healthcare, and consumer opportunities. The team combines entrepreneurial, operational, and technical knowledge with decades of early-stage investment experience.

Since 2005, NLVC has grown as an extensive platform focused on long-term enterprise, healthcare, and consumer opportunities.

• 2022.03

  Reported2022.03.14

  Nutshell Therapeutics completes $40 million Series A+ funding[3]宇道生物完成4000万美元A+轮融资finance.sina.com.cn

  Nutshell Therapeutics announced that it had completed a $40 million Series A+ financing. Yuansheng Capital led the round, with Hengxu Capital co-leading and existing investors also participating.

• 2021.04.15

  Reported2021.04.15

  NGGT completes $30 million Series A financing[4]诺洁贝完成3000万美元A轮融资finance.sina.com.cn

  NGGT announced that it had completed a $30 million Series A financing led by Yipu Capital, with Weidu Capital and existing investors also participating. The proceeds are intended for clinical-product preparation across its gene-therapy pipeline and construction of a cGMP production workshop.

• 2021.02.11

  Reported2021.02.11

  Denglin Technology completes Series A+ funding[5]登临科技完成A+轮融资finance.sina.com.cn

  Denglin Technology completed a Series A+ funding round led jointly by Yuanhe Puhua and Yuansheng Capital, with existing shareholders including Northern Light Venture Capital also investing.

Read more

1. 1NLVC I Global, technology-centric early stage venture capital firm.nlvc.com
2. 2Our Team I NLVCnlvc.com
3. 3宇道生物完成4000万美元A+轮融资finance.sina.com.cn
4. 4诺洁贝完成3000万美元A轮融资finance.sina.com.cn
5. 5登临科技完成A+轮融资finance.sina.com.cn